These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29081246)

  • 1. Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations.
    Xu H; He C; Liu Y; Jiang J; Ma T
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1902-1907. PubMed ID: 29081246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.
    Zhou X; Tao H; Shi KH
    Drug Des Devel Ther; 2018; 12():1-8. PubMed ID: 29296076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase.
    Luo LH; Zheng PJ; Nie H; Chen YC; Tong D; Chen J; Cheng Y
    Drug Deliv; 2016 May; 23(4):1282-90. PubMed ID: 25417833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosylated Chitosan Coated Liposomes of Ledipasvir for Liver Targeting: Chemical Synthesis, Statistical Optimization, In-vitro and In-vivo evaluation.
    Fatouh AM; Elshafeey AH; Abdelbary A
    J Pharm Sci; 2021 Mar; 110(3):1148-1159. PubMed ID: 33039437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide from liposomes optimized by screening design.
    Padakanti AP; Pawar SD; Kumar P; Chella N
    J Liposome Res; 2023 Sep; 33(3):268-282. PubMed ID: 36594184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended release delivery of erlotinib glutathione nanosponge for targeting lung cancer.
    Momin MM; Zaheer Z; Zainuddin R; Sangshetti JN
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1064-1075. PubMed ID: 28758795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation.
    Yang Z; Liu J; Gao J; Chen S; Huang G
    Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
    Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation.
    Wang X; Guan Q; Chen W; Hu X; Li L
    Drug Des Devel Ther; 2015; 9():1805-13. PubMed ID: 25848217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel galactosylated polymers for liposomes as gene drug carriers targeting the hepatic asialoglycoprotein receptor.
    Wang SL; Yu FB; Jiang TY; Sun CS; Wang T; Zhang JH
    J Drug Target; 2008 Apr; 16(3):233-42. PubMed ID: 18365885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.
    Sato A; Takagi M; Shimamoto A; Kawakami S; Hashida M
    Biomaterials; 2007 Mar; 28(7):1434-42. PubMed ID: 17141864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The distribution of azidothymidine palmitate galactosylated liposomes in mice].
    Wu HB; Deng YH; Wang SN; Zhou XY; Wang N; Shi L
    Yao Xue Xue Bao; 2007 May; 42(5):538-44. PubMed ID: 17703780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations.
    Xin Y; Qi Q; Mao Z; Zhan X
    Int J Pharm; 2017 Aug; 528(1-2):47-54. PubMed ID: 28559216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation.
    Chen J; Jiang H; Wu Y; Li Y; Gao Y
    Drug Des Devel Ther; 2015; 9():2265-75. PubMed ID: 25945038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-targeted delivery of liposome-encapsulated curcumol using galactosylated-stearate.
    Li WJ; Lian YW; Guan QS; Li N; Liang WJ; Liu WX; Huang YB; Cheng Y; Luo H
    Exp Ther Med; 2018 Aug; 16(2):925-930. PubMed ID: 30112045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of liposomal bifendate in liver following intravenous injection in mice.
    Zhipeng C; Jiabi Z; Hongxuan C; Yan-yu X; Jun C; Bao-chang C
    J Drug Target; 2010 Sep; 18(8):627-36. PubMed ID: 20166805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes.
    Garg M; Dutta T; Jain NK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):76-85. PubMed ID: 17303396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.